Given that p300/CBP also plays a key role in asthma-related inflammation and airway remodeling, these findings underscore a shared epigenetic mechanism, suggesting that insights from ARDS may help identify novel therapeutic targets for severe or steroid-resistant asthma. This evidence concerns the gene EP300 and acute respiratory distress syndrome.